HER2 Support Group Forums - View Single Post - FDA approves Verzenio for advanced metastatic breast cancer

News · 10-02-2017, 12:40 PM

The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

More...

10-02-2017, 12:40 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,954	FDA approves Verzenio for advanced metastatic breast cancer The U.S. Food and Drug Administration (FDA) has approved a new drug Verzenio (abemaciclib) for the treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. More...